|
|
 |
|
Viewing report
|
|
|
|
Drug and Device Combination (2009 - 2014)
MarketsandMarkets.com, July 2009, Pages: 222
Drug device combination is defined as the combination of drugs and medical devices that can be chemically or physically united or co-packaged as separate, cross labeled products. The commercialization cycle from R&D to product shows the immense potential of bundled offering. Currently, the market has a potential of US$10.6 billion and has been experiencing a growth of 15% CAGR for past two years. In the next five years, the market is expected to grow at a CAGR of 11.8%.
Untapped market potential and benefits are the primary factors for the early adoption. The other market factors contributing are relatively shortened product approval time with the establishment of Office of Combination Products (OCP) within the FDA. An increase in the number of cardiovascular patient population has also facilitated the early acceptance of the drug device combination products. This is supported by the fact that cardiovascular applications constitute about 64% of the entire drug-device combination applications market. A future view of the drug-device combination is that these next generation products will make single component medical devices obsolete.
Europe and the U.S. hold major share of the global drug-device combination market. The growth of the market in these countries is driven by growing ageing population and improvements in medical science and biotechnology that enables new product development. The emerging economies such as the BRIC (Brazil, Russia, India, China) nations also represent a high growth potential in this developing market.
Market estimates and forecast
The report provides in-depth market estimates and forecasts for the global weight management market. The segmentation is as follows:
Drug device combination – products
Antimicrobial catheter, advanced wound care products, bone graft substitutes, antibiotic bone cements, drug eluting stents, photodynamic therapy, closed loop glucose monitor and insulin pump, steroid eluting electrodes and others.
Drug device combination – application
Bone treatment, cancer treatment, diabetes treatment, skin care treatment, antimicrobial applications, urological treatment, non cardiovascular treatment, cardiovascular treatment, ophthalmic treatment, others.
Drug device combination – technology
Bone graft substitutes.
Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 50 company profiles for each of its sub-segments.
What makes our reports unique?
- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
- Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and a minimum of 50 micro markets, which are collectively exhaustive and mutually exclusive.
- No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies - US, Europe, APAC, ROW.
- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.
Key questions answered:
- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?
Customers who bought this item also bought
Drug Delivery for Self-Administration Report - Technologies, Combination
Getting Maximum Benefit from Combination Products
Development and Approval of Combination Products: A Regulatory Perspective
Injectable Drug Delivery
Medical Device Development: Regulation and Law, All New Edition!
Drug Therapeutics: Therapeutic Proteins
Design, Execution, and Management of Medical Device Clinical Trials
Baxter International Medical Device Company Intelligence Report
Cordis Medical Device Company Intelligence Report
Commercial Insight: Asthma & COPD - Combination products still have blockbuster potential
Medical Device Development: A Regulatory Overview
Drug Delivery in Cancer - Technologies, Markets and Companies
|
|
|
|
